To evaluate and compare the efficacy C-11 acetate PET, F-18 FDG PET and MRI in detecting brain tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004468

Enrollment

129

Registered

2019-11-25

Start date

2012-01-17

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : 60 minutes after administration of 185 MBq F-18 FDG to brain tumor patients, F-18 FDG PET images were taken and MRI was performed. The following day, PET images were obtained 10 minutes after

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult men and women over 20 years old 2. First diagnosed patient with primary brain tumor

Exclusion criteria

Exclusion criteria: 1. Patients who received chemotherapy or radiation therapy before surgery. 2. Pregnant patient 3. Patients or guardians who do not understand or do not accept consent 4. Uncontrolled Diabetics

Design outcomes

Primary

Measure	Time frame
The SUV results of the preoperative C-11 Acetate PET are compared with the conventional imaging technique (NPO F-18 FDG PET, MRI).	—

Secondary

Measure	Time frame
SUV results of preoperative C-11 Acetate PET are compared with conventional imaging techniques (NPO F-18 FDG PET, MRI) to compare the prognostic predictive power of patients.	—

Countries

Korea, Republic of

Contacts

Public ContactDongwoo Kim

Yonsei University Health System, Severance Hospital

kdwoo@yuhs.ac+82-2-2228-4852

Outcome results